Connecticut Innovations has hired a former Novartis Institutes biomedical research and development executive to play a key role in its $200 million bioscience innovation fund.
Jeremy Crisp, who was based out of Novartis’ Groton facilities, will assume the title of executive vice president and chief innovation officer, a new position created by the quasi-public CI.
His role will be to work with bioscience organizations in Connecticut to transform intellectual talent and capital into measurable economic benefit, CI said.
Before his work with Novartis, Crisp spent six years at Pfizer, where he managed global R&D partnerships.
“It is unusual to find someone with such a depth and breadth of experience—someone who has enabled bioscientific innovation from so many different angles,” Claire Leonardi, chief executive officer of CI, said in a statement.
